Publication | Closed Access

2-Nitroimidazol-5-ylmethyl as a potential bioreductively activated prodrug system: reductively triggered release of the parp inhibitor 5-bromoisoquinolinone

Medicinal ChemistryPharmaceutical SciencePharmacological StudyBiochemistryMedicineNatural SciencesProdrug SystemParp Inhibitor 5-BromoisoquinolinonePharmacological AgentPharmacotherapyPharmacologyPharmaceutical ChemistryDrug Discovery